Cardiopulmonary exercise testing (CPX) may improve the diagnostic accuracy of standard exercise ECG for detecting exercise-induced myocardial ischemia in patients with suspected or confirmed CAD.
Heart disease is a major cause of morbidity and mortality in the United States, with coronary artery disease (CAD) representing more than half of all cardiovascular events. Stable patients presenting with symptoms suggestive of CAD are likely to undergo an exercise electrocardiogram (ECG) and/ or imaging study as a first-line diagnostic assessment. A cardiopulmonary exercise test (CPX) is an ECG stress test plus ventilatory gas analysis. Recently, CPX has been used to detect exercise-induced myocardial ischemia (EIMI) suggestive of underlying CAD. Two CPX variables, oxygen pulse (VO 2 /HR) and the slope of oxygen consumption versus work rate (Δ VO 2 / Δ WR), have been identified to be especially indicative of EIMI. Currently, there are a number of diagnostic tests available for the identification of CAD, with the most widely used being stress ECG, stress myocardial perfusion imaging (MPI) and echocardiography, and cardiac catheterization. Exercise ECG, although inexpensive, has a number of well-recognized limitations, including low sensitivity resulting in false-negative results. Stress (exercise or pharmaceutically induced) MPI and catheterization are more accurate but also more invasive and expensive. It appears that CPX may improve the diagnostic accuracy of exercise ECG. This review will address the potential utility of CPX in patients with suspected or confirmed myocardial ischemia.
Pinkstaff et al. (Tue,) conducted a review in Suspected or confirmed myocardial ischemia. Cardiopulmonary exercise testing (CPX) vs. Exercise ECG, stress MPI, echocardiography, and cardiac catheterization was evaluated. Cardiopulmonary exercise testing (CPX) may improve the diagnostic accuracy of standard exercise ECG for detecting exercise-induced myocardial ischemia in patients with suspected or confirmed CAD.